Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BRAVE BISON GROUP PLC Major Shareholding Notification 2018

Oct 31, 2018

7530_mrq_2018-10-31_ad66de05-85e3-42ae-bf59-f8fc48f03a2b.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7778F

Brave Bison Group PLC

31 October 2018

31 October 2018

Brave Bison Group plc

("Brave Bison" or the "Company")

Holding(s) in Company

Brave Bison announces that is has been advised by Simon Davies that, following recent share purchases, he is now directly and indirectly interested in 19,166,559 ordinary shares in the Company, representing 3.33 per cent. of the Company's issued share capital.

-ENDS-

For further information, contact: 

Brave Bison Group Tel: 020 7183 4545
Claire Hungate, Chief Executive Officer
Allenby Capital Limited Tel: 020 3328 5656
Virginia Bull / Jeremy Porter
Redleaf Communications Tel: 020 3757 6880
Elisabeth Cowell / Fiona Norman [email protected]

About Brave Bison

Brave Bison is a social video company, proudly working with some of the biggest brands and most followed YouTube and Facebook talent in the world. Clients include P&G, Shell, PUMA and Hyundai.

Brave Bison makes it simple for content owners, creators, brands, publishers and platforms to unlock the value of online video, whether on a licensed, ad-funded, direct to consumer or paid placement basis.

The business is based in two regions - Europe, with headquarters in London; and APAC, with offices in Singapore.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

HOLMBBPTMBIJMIP